Dr Anjali Pathak discusses four cases of skin cancer or pre-cancer - involving potentially malignant skin lesions - and their management ...

Fungabeam Laser Device 2025 - Advanced low-level laser technology to eliminate nail fungus safely at home. Painless, chemical-free, and effective.

FDA-Registered Home Laser Technology Gains Rapid Adoption During Winter Season as Year-End HSA/FSA Deadlines Drive 290% Search Surge-Podiatrists Report Clinical-Grade Results Without $2,500+ Professio ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...

Discover the best hair loss treatments for every hair type, budget, and routine. These serums, shampoos, and pills are all ...

The FDA has approved Zoryve (roflumilast) cream 0.05% for the topical treatment of mild to moderate atopic dermatitis in children 2 to 5 years of age.

Experts discuss the foundational role of topical therapies in pediatric atopic dermatitis management, highlighting the ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Noticing a receding hairline? You’re not alone — and thanks to ...

In real-world clinical practice, managing atopic dermatitis presents many challenges, particularly when ideal treatments are ...

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for ...

The 2025-26 NFL regular season is in full swing, and Week 4 saw a few interesting results (New York Giants beating the Los Angeles Chargers outright as 6.5-point home underdogs and Cowboys-Packers ...

INDICATIONS ZORYVE cream, 0.05%, is indicated for topical treatment of mild to moderate atopic dermatitis in pediatric patients 2 to 5 years of age. ZORYVE cream, 0.15%, is indicated for topical ...